
Manufacturing roundup: Canada to invest $58M+ into 'critical' medicines manufacturing; FDA to accept apps for CMC pilot
Canada’s government will invest $58.6 million over five years to support the Canadian Critical Drug initiative and 350 jobs.
The initiative plans to boost the R&D and manufacturing sector in the province of Alberta and is spearheaded by the not-for-profit Applied Pharmaceutical Innovation (API), which helps life science companies in the commercialization phase.
The funding will help push forward a new 40,000 square foot manufacturing site in Edmonton to produce “critical” medicines, but the specific products were not immediately announced. The facility, once completed, will be able to produce 70 million doses annually. The funds will also go toward upgrading API’s existing R&D facility in Edmonton as well as other R&D programs and clinical trial support.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.